Worldwide, each year over 30,000 patients undergo an allogeneic hema-topoietic stem cell
transplantation with the intent to cure high-risk hematologic malignancy, immunodeficiency …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Despite the achievements that have increased viability after the transplantation of allogeneic
hematopoietic stem cells (aHSCT), chronic graft-versus-host disease (cGVHD) remains the …

Haematopoietic stem cell transplantation (HSCT) is the treatment of choice for malignant
haematological diseases. Despite continuous improvements in pre-and post-transplantation …

Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic
hematopoietic cell transplantation and a leading cause of long-term morbidity, nonrelapse …

Background Extracorporeal photopheresis (ECP) is an effective treatment for graft‐vs‐host‐
disease (GvHD). Photopheresis can be performed in offline or inline method. The first uses a …

Hematopoietic stem cell donation is a method used to treat both blood-related and non-
blood-related malignancies. Graft-versus-host disease is a potentially life-threatening …

Background and objectives Extracorporeal photopheresis (ECP) is one of the second-line
treatment strategies in steroid-refractory acute graft-versus-host disease (aGvHD). We aimed …

Extracorporeal photopheresis (ECP), an immunomodulatory therapy for the treatment of
chronic graft-versus-host disease (cGvHD), exposes isolated white blood cells to …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …